Behandling med doxazosin har vist sig at resultere i regression af venstreventrikel- hypertrofi, hæmning af trombocytaggregation samt øget kapacitet af vævsplasminogen- aktivator.
Treatment with doxazosin has been shown to result in regression of left ventricular hypertrophy, inhibition of platelet aggregation as well as enhanced capacity of tissue plasminogen-activator.